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INTRODUCTION 
Vicharchika is described under Kshudra Kushtha in 
Ayurvedic texts and also mentioned as a curable 
disease yet the relapsing nature of this disease makes 
it of stubborn nature. The disease can be  correlated 
with  ‘Eczema’ in modern medical science. The exact 
etiopathogenesis is not yet clear. 
This disease has been correlated with modern disease 
‘eczema’ by many authors. About 30% of all the skin 
diseases is eczema. It is always difficult to trace out 
the exact cause of disease, because it may be 
associated with the occupation, hobbies, diet, clothes, 
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cosmetics or other articles that the patient is exposed 
to during his routine life. Besides so much work on 
this disease a successful treatment is still not possible 
in any system of medicine. The present work is 
another attempt in this direction. 
In context of skin disease, multiple drugs are 
prescribed in classics. In Brihatrayi, so many 
references of Saptaparna in Kustha Chikitsa are 
available. Especially Charaka has mentioned 
Saptaparna in Kushthagna Dashemani.
[1]
 Mainly 
prescribed  in Krimi, Shwasa, Kushtha, Gulma, 
Vranachikitsa. Even Nighantus have  mentioned the 
therapeutic utility of Saptaparna. i.e. Bhavprakasha 
Nighantu, Dhanvantari Nighantu, Shodhala Nighantu, 
Raj Nighantu etc. In all the Nighantus, the therapeutic 
use of Saptaparna in Kustha is indicated. So far no  
research work has been carried out on Saptaparna in  
Vicharchika Roga. So, Saptaparna drug was selected 
for the clinical study. According to Bhavprakash 
Nighantu, Saptaparna is under Haritakyadi Varga in 
Kushtha Chikitsa.
[2]
 
OBJECTIVE OF THE STUDY 
To study the therapeutic efficacy of the drug 
Saptaparna in the management of Vicharchika. 
A B S T R A C T  
Skin diseases are very commonly seen in today's era due to irregular food habits and awkward 
lifestyle. Each and every person is being suffered from the same irregular lifestyle. Due to the same 
there is a need to discover the drug which can be administered in the skin without any side effects. 
There are many references found regarding treatment of Vicharchika (Eczema) in Ayurvedic texts but 
we need the drug which can act like a magical tool in the management of Vicharchika (Eczema). In 
Bhavaprakash Nighantu, efficacy of Saptaparna (Alstonia scholaris Linn.) has been mentioned in 
Kushtha. So, this clinical trial had been carried out to evaluate effect of Saptaparna Twak Churna in 
management of Vicharchika (Eczema).  
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MATERIALS AND METHODS 
Source of drug 
The test drug Saptaparna had been collected from the 
forest area near Vadodara. After the collection of 
Saptaparna Twak, its identification and 
standardization had been done.This drug had been 
sent to Pharmacy of Parul Institute for making Churna 
of this drug. 
Criteria for selection of patients  
Patients with characteristic signs and symptoms of 
Vicharchika were selected from the O.P.D. and I.P.D. 
Sections of Parul Sevashram Hospital, Waghodiya, 
Vadodara, irrespective of their Age, Sex, Religion, 
Occupation etc. Simple random sampling technique 
was chosen for selection of the Patients. 
Criteria for diagnosis 
For diagnosis purpose the classical signs and 
symptoms described in different Samhitas have been 
taken up. A detailed Performa incorporating all the 
classical signs and symptoms of the disease has been 
prepared. Also Dusti Laksanas of Dosa, Dhatu, Dusya, 
Agni and Prakrti etc. have been taken up in the 
Proforma. 
Exclusion Criteria 
 Diabetes prone patients.  
 Chronicity more than 3 yr.  
 Non co-operative patients.  
 Patients having severe bleeding ulcers , Vericosity, 
Malignancy etc. 
 Patients having excessive purulent discharge. 
Investigations 
 Routine haematological, urine and stool 
examinations were carried out before and after 
treatment. 
 Blood sugar level was examined before treatment 
to exclude the Patients of diabetes and diabetes 
prone patients.  
Diet 
 Patients are advised to take their routine normal 
diet, barring certain dietary constituents that are 
likely to exacerbate the condition following the 
dietetic constituents mentioned in the Samhitas.  
 Patients are advised to maintain good hygienic 
condition.  
 Patients are also advised to follow all the 
‘Pathyapathya’ regarding to Vicharchika.  
Treatment Groups 
 Group : Drug : SaptaparnaTwak Churna 
 Dose : 3 gm / 2 times 
 Anupana : luke warm Water 
 Duration : 8 week 
OBSERVATION AND RESULTS 
The clinical study was carried out in 30 patients of 
Vicharchika divided into three groups, which are 
randomly selected for the purpose. The observations 
made are systematically presented, first taking down 
general data like age, sex, marital status, religion etc. 
and followed by routine urine, stool and 
hematological investigations.  
Age: All the patients in this study were categorized 
into 6 age groups and maximum 30.00% patients were 
of 11-20 years, followed by 23.33% in age group 41-50 
years, 20.00% in 21-30 years, whereas 13.33% were in 
31-40 years age group. This indicates the prevalence 
of Vicharchika in (11-50 years) middle age group. It 
may be due to exposure to many factors related to 
work and other environmental factors too. 
Sex: Female predominance 53.33% was evident from 
the table. It is just because they are more exposed to 
allergens related to dust, detergents, vegetables, 
cosmetics, jewellary, etc. which provokes the disease.  
Religion: Maximum no. of patients i.e. 73.33% 
belonged to Hindu religion, 26.66% were Muslims. 
This may be due to the area where the study was 
performed. But Muslim community is more prone due 
to excessive intake of non vegetarian food. 
Occupation: Maximum 40.00% patients were 
housewives, 30.00% patients students, 10.00% 
patients were servicemen, 06.66% patients were 
bussiness men. Occupation always affects the disease 
due to exposure to allergens and here maximum no. 
of patients were housewives, as housewives are more 
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exposed to allergens related to dust, detergents 
(mainly), vegetable etc. which provokes the disease. 
Education: On considering the educational 
qualification it was found that maximum 30.00% 
patients were graduates, 23.33% primary education 
and 13.33% were uneducated.  
Marital Status: Maximum 70.00% patients were 
married while 30.00% patients were unmarried. Infact 
marital status as such cannot affect the disease.  
Socio economic status and Residential area: 
Maximum 36.66% patients were reported middle 
class, 26.66% from lower middle class; only 16.66 % 
patients were from lower class.  
The data favors that this affects the hygiene and other 
nutritional factors. Some people cannot afford the 
treatment and some people worsen the condition by 
handling the problem more often by various types of 
medicines.  
Maximum 53.33% were belonging to Rural area where 
as 30.00% were from city area, 10.00% and 06.66% 
were from Urban and Town. The data favors that the 
change in lifestyle and exposure to pollution like 
factors provoke the disease especially in Rural area 
where these factors are comparatively less than other 
area. 
Addiction and Diet: Maximum 73.33% patients were 
addicted to tea, 26.66% to coffee, 16.66% and 13.33% 
patients each were addicted to Smoking and Tobbaco, 
10.00% patients had the addiction of Alcohol. 
Addictions can prone or increase the disease and can 
reduce the effect of medicines.  
Maximum patients were vegetarians, 36.66% were 
taking mixed diet. Here the study area is mainly 
vegetarian. Otherwise non vegetarians may be 
affected more.  
Past history and Family History: Maximum 63.33% 
patients had no significant past history only 23.33% 
had a positive past history of skin disease. 
Maximum 70.0% patients had negative family history 
and 30.0% patients had positive history. As per 
Sushrutacharya Kustha (Vicharchika) can create 
Bijadushti and goes through parents to child. 30% 
patients are supporting this theory.  
Chronicity and Affected part: Maximum 43.33% 
patients had a chronicity of disease for 6-12 months. 
Maximum affected area was upper extremities in 
50.0% patients, 36.66% patients were having lesions 
in lower extremities. 6.66% had all over body. As per 
Sushrutacharya, Vicharchika is found commonly on 
legs and hands. It may be due to more exposure to 
the allergens which provoke the disease.  
Sharira, Manasa Prakruti and Dosha: Maximum 
53.33% patients were having Kapha-Vata Prakruti and 
Maximum 66.66% patients were having Tamasika 
Prakruti and Maximum 43.33% patients were having 
Kapha Dosha dominant Lakshana of Vicharchika. All 
Acharyas say that Vicharchika is a Kaphapradhana 
Vyadhi, the above data supports the matter.  
Agni and Ahara Shakti: Maximum 43.33% patients 
were having Mandagni and maximum 53.33% 
patients were having Madhyama Ahara Shakti. In 
both conditions, if patient does Apathyasevan, it 
causes improper digestion. And this leads to 
Amlapitta which can vitiate the Dosha which then 
creates Shaithilya in Dhatu to create the disease. 
Vyayama Shakti: Maximum 56.66% patients had 
Avara Vyayama Shakti. Vyayama is most important 
factor to make our body fit and also it can fight 
against the disease. 
Satva, Sara and Samhanan: 43.33%, 56.66%, and 
63.33% patients were having respectively 
Madhyamsatva, Sara and Samhanan. The persons 
having Avarasatva require more time and counseling 
as compared to Madhyama and Pravarasatva. So they 
have to be checked properly. If the disease occurs 
then Pravarasara and Samhanan are easily cured, 
whereas Madhyama and Avarasara and Samhanana 
get affected more and do not get cured fast in 
comparison to Pravarasara and Samhanana.  
Pradhana Rasa and Nidana Sevana: Maximum 40% 
patients were taking Madhura Rasa as a Pradhana 
Rasa. 23.33% Katu, 16.66% of each Amla and Lavana  
were taken by the patients. Here Madhur, Amla, and 
Lavan Rasa increase Kapha Dosha. Amla, Lavan and 
Katu Rasa can do Dusti of Rakta. All are the 
responsible factors for development of the 
Vicharchika. Maximum 40.00% patients were taking 
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Virudhaahara, 23.33% did Mithyaahara, 20.00% 
Mithyavihara was followed by the patients. All these 
factors are responsible to develop and increase the 
disease Vicharchika.  
Rupa of Vicharchika: Kandu and Vaivarnya were 
observed in all the patients. Raukshta in 43.33%, 
Pidika in 33.33%, Srava in 23.33%, Ruja in 30%, Daha 
in 20%, Raktima and Paka in 6.66 % were found in the 
patients. The above observation indicates the 
dominance of Kapha – Vata followed by Pitta. This 
variation happens due to the Prakruti of patients and 
variation in Hetu Sevana.  
Effect of therapies 
Effect of Saptaparna Twak Churna  
Test shows effect of Saptaparna Twak Churna on the 
signs and symptoms of Vicharchika. 74.00% decrease 
in Srava which was (<0.001) statistically highly 
significant, Kandu – 42.38% and Vaivarnya - 50.38% 
both they were statistically (<0.01) significant 
decrease. And Raukshata – 42.72% (<0.01) was found 
statistically significant. 
 
Total effect of therapy 
No any patient was relieved complete relief. Only 
12.50% patients were found in markedly improved 
and 50.00% in moderately improved. Where partially 
improved patients were also 50.00% and 12.50% 
patients were found who had complained of no 
change. 
CONCLUSION 
Clinical study conclude that Saptaparna is more 
beneficial where systemic involvement is present with 
somatic symptoms like Vibandha, Pindikodvestana, 
Bhrama, Daurabalya etc. Saptaparna is more effective 
in Srava, Kandu and mild effective in Raukshata and 
Vaivarnyata. No any significant changes were 
observed in some symptoms like Raktima, Paka, 
Daha, Shotha.  
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